Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 237 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2692 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-MIRTAZAPINE 30MG TABLET Resolved 2023-11-17 2023-12-01 210662
APO-MIRTAZAPINE 45MG TABLET Resolved 2023-12-08 2023-12-15 212922
APO-MIRTAZAPINE 30MG TABLET Resolved 2023-12-22 2024-02-09 214244
APO-MODAFINIL 100MG TABLET Resolved 2022-02-04 2022-02-22 154181
APO-MODAFINIL 100MG TABLET Resolved 2023-08-12 2023-10-27 201707
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2017-07-17 2017-08-18 15959
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2019-01-30 2019-02-01 74022
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2020-10-28 2020-11-02 127367
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-09-01 2022-09-15 168418
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2023-06-29 2024-01-19 196946
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-19 2024-01-19 216669
APO-MONTELUKAST 10MG TABLET Resolved 2017-12-14 2018-02-15 32813
APO-MONTELUKAST 10MG TABLET Resolved 2018-05-31 2018-10-05 50956
APO-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2018-08-09 2018-10-16 57792
APO-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2018-10-11 2018-10-16 63793
APO-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2019-01-15 2020-04-07 72357
APO-MONTELUKAST 10MG TABLET Resolved 2019-03-13 2019-05-06 78529
APO-MONTELUKAST 10MG TABLET Resolved 2019-09-18 2019-11-25 94171
APO-MONTELUKAST 4MG TABLET (CHEWABLE) Resolved 2019-11-20 2020-04-07 99311
APO-MONTELUKAST 4MG TABLET (CHEWABLE) Resolved 2020-05-13 2020-07-06 114949

Showing 1661 to 1680 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-01-26 217493
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496

Showing 81 to 100 of 356